Close Menu

NEW YORK (GenomeWeb) – Abreos Biosciences and True Diagnostics have agreed to collaborate on the development of point-of-care tests that can validate the identity and activity of biologics and biosimilars for use in cancer, autoimmune diseases, and other chronic illnesses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.